PRISMAP+ -Furthering the European Medical Radionuclide Programme started on 1 May 2026 and will run for 3 years. The project brings together 21 beneficiaries, 3 associated partners and 4 collaborative partners to strengthen and expand access to innovative medical radionuclides and related services across Europe.
Following the Pre-Kick-off Meeting held on 1 April 2026, the First PRISMAP+ Consortium Meeting will bring together the project partners to discuss the progress and activities since the start of the project, as well as the upcoming priorities and next steps.
The meeting will include Work Packages , Supporting Bodies and general assembly providing an opportunity for partners to exchange on the scientific, technical and organisational developments of PRISMAP+.
The PRISMAP+ -Furthering the European Medical Radionuclide Programme project is co-funded by the European Commission under the Horizon Europe Research Infrastructures Programme.